The 39 year-old star of TV, film and stage has battled with the potentially fatal condition since his early 20s, but has ...

The market is segmented by product types, including general-purpose infusion pumps, such as large-volume, syringe, electronic ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Insulet ( (PODD) ) has released its Q3 earnings. Here is a breakdown of the information Insulet presented to its investors. Insulet ...

Insulet raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps.

Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days, a 25% ...

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

PharmaSens, a developer of innovative insulin patch pumps for people with diabetes, has announced the appointment of Robert A. Gabbay, MD, PhD, FACP and James L. Peterson to its board of directors.

Bernstein initiated coverage of Insulet (PODD) with an Outperform rating and $300 price target Innovation is driving accelerated insulin pump ...

Allie Goecke-Butler didn't choose to get diabetes at 24 and become insulin dependent, but yet she says, "staying alive is becoming more and more expensive." ...